Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 2Phase 4 1Phase 3 1Phase 1/2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 4Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Thyroid Cancer, Papillary 1Sarcoma, Endometrial Stromal 1Neoplasm Metastasis 1Liver Neoplasms 1Leukemia, Hairy Cell 1Duodenal Neoplasms 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Anatomic Stage I Breast Cancer AJCC v8 1Agnosia 1Adrenocortical Adenoma 1Adenocarcinoma, Follicular 1

Interventions

Docetaxel 137Prednisone 120Abiraterone Acetate 91Leuprolide 86enzalutamide 84Radiotherapy 59bicalutamide 56Magnetic Resonance Spectroscopy 54Goserelin 54Androgen Antagonists 51acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 47apalutamide 44abiraterone 34Radiosurgery 31Specimen Handling 30gallium 68 PSMA-11 29Gonadotropin-Releasing Hormone 29cabazitaxel 28Carboplatin 27darolutamide 25Estramustine 24luprolide acetate gel depot 23relugolix 22Metformin 22Triptorelin Pamoate 20sipuleucel-T 19radium Ra 223 dichloride 19Radiation 19pembrolizumab 18deltacortene 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Prostatic Neoplasms × High-Energy Shock Waves × Clear all
NCT05828082 2026-05-13

Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT01193855 2013-08-26

Dutasteride in Treating Patients With Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
42 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡